Go to the list of all blogs
Serhii Bond's Avatar
published in Blogs
Aug 03, 2023

Therapy Stock Review: Outstanding 10.96% Weekly Gain $BIIB, $URGN, $ALLO

Thriving in Therapy: A Deeper Look into the Biotech and Pharmaceutical Theme

Overview of the Therapy Theme
Theme Therapy +10.96% - 1W change
Swing trader: Long-Short Equity Strategy (TA&FA) Annualized Return + 64% and Swing trader: High Capitalization (TA) Annualized Return + 7%

As the world grapples with various health challenges, the need for innovative therapeutic solutions cannot be overstated. In the financial market, the Therapy theme represents an intriguing investment opportunity. This theme focuses on biotech and pharmaceutical companies that discover, develop, manufacture, and deliver therapies for treating various diseases and disorders. The industry is part of the overall healthcare field but has a specific focus on the development of treatments to cure or prevent diseases.

This theme includes tickers such as $ACRS, $ALLO, $ALNY, $ARVN, $BIIB, $BPMC, $EVLO, $INMB, $KRYS, $LIVN, $OCUL, $URGN, $USPH, and $VKTX. These companies are diverse in their operations but united by their commitment to developing and delivering life-saving therapies.

Market Capitalization Analysis

These therapy-themed companies boast a collective average market capitalization of $5.8B, with individual valuations ranging from $153.8M to a whopping $39.1B. Leading the pack is Biogen ($BIIB) with the highest valuation of $39.1B, while Immune Bio Inc. ($INMB) trails with the smallest market cap at $153.8M.

A Peek into Performance: Allogene Therapeutics ($ALLO), UroGen Pharma ($URGN), and Biogen ($BIIB)

Allogene Therapeutics ($ALLO)

Allogene Therapeutics has demonstrated some volatility in its performance. For instance, the company experienced a notable downtrend with a -6.62% decrease on July 25, 2023, and a -8.49% fall on July 15, 2023. However, the company also showed resilience with a +9.61% jump on July 7, 2023, indicating an uptrend reversal. This fluctuation in performance demonstrates the dynamic nature of the biotech industry.

UroGen Pharma ($URGN)

UroGen Pharma, on the other hand, has been a high flyer in the Therapy theme, exhibiting the highest price growth at 129.64%. This significant growth reflects the company's innovative approach to developing and commercializing therapies designed to change the standard of care for urological pathologies.

Biogen ($BIIB)

Biogen, the heavyweight in this theme, demonstrates why it commands such a massive market capitalization. With a valuation of $39.1B, the company continues to be a major player in the industry, providing a wide array of therapies for diseases such as multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy, among others.

Volume Fluctuation Analysis

The average weekly volume growth across all stocks in the group stands at 95.5%. Allogene Therapeutics ($ALLO) experienced a record-breaking daily growth of 1,009% of the 65-Day Volume Moving Average on June 24, 2023. On May 26, 2023, US Physical Therapy ($USPH) had a similar record-breaking daily growth of 1,369% of the 65-Day Volume Moving Average. Krystal Biotech ($KRYS) also experienced a significant two-day consecutive volume increase, resulting in a daily growth of 178% of the 65-Day Volume Moving Average on May 25, 2023. These volume fluctuations provide an insightful look into investor interest and trading activity within the Therapy theme.

Fundamental Analysis Ratings

Fundamental analysis ratings provide another valuable perspective on the health and potential of companies within this theme. On average, companies in this theme have a Valuation Rating of 72, P/E Growth Rating of 88, a Price Growth Rating of 51, an SMR Rating of 91, and a Profit Risk Rating of 83. The Seasonality Score stands at 15. These scores indicate the overall health and potential for growth of these companies, offering another piece of the investment decision puzzle.

The Therapy theme offers a myriad of opportunities for investors who are passionate about healthcare and the development of novel therapeutic treatments. The performance of the companies under this theme not only shows their potential for growth but also the crucial role they play in improving global health outcomes.


Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 80.56B. The market cap for tickers in the group ranges from 72.83K to 524.29B. LLY holds the highest valuation in this group at 524.29B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -3%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -3%. AZNCF experienced the highest price growth at 3%, while SCLX experienced the biggest fall at -17%.


The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 7%. For the same stocks of the Industry, the average monthly volume growth was 14% and the average quarterly volume growth was 34%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 28
P/E Growth Rating: 61
Price Growth Rating: 56
SMR Rating: 57
Profit Risk Rating: 67
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

225 Binney Street
+1 617 679-2000
Interesting Tickers
1 Day
MFs / NAMEPrice $Chg $Chg %
Vanguard Energy Index Admiral
American Beacon Shapiro Equity Opps Y
Gabelli Asset C
Janus Henderson Global Sust Eq T
Putnam Focused Equity R

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AZN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AZN could also see price increases.

Ticker /
1D Price
Change %
Loosely correlated
Poorly correlated
Poorly correlated
Poorly correlated
Poorly correlated
Some of the world’s biggest financial institutions have devoted multi-million dollar budgets to developing algorithms that can find patterns in the market, identify trends, and perform automated trading designed to take advantage of even the smallest price movements. The AI revolution is so big that as it stands today, the world’s five biggest hedge funds all use systems-based approaches to trade financial markets.Indeed, quantitative trading hedge funds now manage $918 billion (according to HFR), which amounts to 30% of the $3 trillion hedge fund industry – a percentage continues to grow with each year that passes.
Where smaller, more volatile companies can placate shareholders with higher returns, larger companies often use dividend payouts to entice new investors and hold their existing ones. These low-risk options may not work for every investment approach, but dividend-producing stocks can offer great benefits under the right circumstances – especially for portfolios built for the long-term.Beyond the ability to rely on these semi-regular payouts as an income stream – a strategy favored by retirees – dividends are an excellent vehicle for compounding earnings through reinvestment.
Artificial intelligence (AI) and fintech have an inherent compatibility that has become clearer as each sector has matured, with recent growth and successes on their own accord bringing new ideas about how they can work together.AI can analyze information at far greater quantities (and far more quickly) than any human, making it a natural fit to help fintech firms streamline and automate processes that benefit customers and businesses alike. Fintech has brought a revolution of convenience to the finance world.
You’ve set up your bitcoin wallet and have acquired some bitcoins, and now you’re ready to use them – what’s next?But be VERY careful to double- or triple-check that the address is correct – crypto transactions are irreversible, and a typo almost certainly means permanently losing the bitcoins you were trying to send. One way to avoid potential slip-ups is to scan a QR code (when available) for the destination address.
Mainstream acceptance has come in fits and starts, with regulatory approval proving hard to come by for a variety of reasons – not least of which the ever-present risk of theft via hacking or other means, which pose an especially large obstacle to attracting investment from mainstream institutions. Because crypto holdings are only accessible via a specific private key, they are susceptible to loss – literally, if the key is written on a piece of paper or a physical hard drive, methods of offline ‘cold storage’ – or through hacks if held in an online wallet.Reuters reports that over $800 million in crypto assets were stolen in the first half of 2018, creating justifiable concern for both owners and mainstream financial institutions alike. Some type of insurance coverage would potentially mitigate the risks inherent to owning crypto assets – if insurers are willing to play ball.
Don't fall prey to common financial traps that can derail your financial planning efforts. In this article, we highlight four traps to keep in mind, including the importance of refinancing rather than consolidating student loans and credit card debt, prioritizing debt repayment over investments, limiting news consumption, and understanding the true costs of buying a home. Learn how AI tools from Tickeron can help investors make informed decisions and achieve their investment objectives.
Paper wallets are extremely useful tools – beyond being one of the most popular and secure cold storage methods, they make it simple to transfer coins between owners.You can access the funds on your paper wallet by “sweeping” (or importing) them to either a live wallet (like Trezor or Exodus) or an exchange service (like Coinbase). Most services allow you to import them directly from your wallet’s private key, but there are two key exceptions.
Get ready to revolutionize your investment strategy! Discover 3 cutting-edge ways to get fresh and innovative investment ideas, and say goodbye to relying on unreliable sources like CNBC. From utilizing advanced AI tools to sharing your portfolio with trusted friends, these methods are sure to boost your investment game. So, what are you waiting for? Read on to find out how you can start generating new ideas today!
You’re a trader, not an investor. It’s important that you understand the difference before choosing an actual trading style. Traders perform their magic over shorter periods of time, sometimes within minutes or hours. Investors are more passive. They purchase equities and hold them for months or years, relying on a long-term return. Traders evaluate buys and sells based on technical analysis...
Looking to invest your money in the stock market? While leaving your money there for a few years can yield a ten percent return, real traders know that actively trading and using derivatives is the way to make a significant profit while minimizing risk. Derivatives are contracts between two parties that are based on the price of a financial asset, such as a stock or bond. The value of the...
Zoom (ZOM), the video conferencing giant, registered a three-day uptrend of +1.84%. Our proprietary AI trading bot identified an intraday gain of 6.75%, attributing it to robust market sentiment and promising growth indicators. This uptrend signals a potentially strong position for investors and stakeholders. A deeper analysis could provide crucial insights into the future performance of ZOM. Stay updated for further analytics and forecast from our AI tools.
The Swing Trader: Volatility Balanced Strategy (TA) AI trading robot has emerged as a remarkable performer. Operating within our robot factory, this trading algorithm has recently demonstrated its prowess by generating a notable gain of 3.74% while trading ZIM (ZIM Integrated Shipping Services Ltd) over the previous week. This article aims to delve into the technical analysis surrounding ZIM's recent performance and the potential for an impending price rebound.
AI trading robot, the Swing trader: Volatility Balanced Strategy (TA), has stood out as a performer in our robot factory. In the previous week, it achieved an impressive 3.78% gain while trading AFRM (Affirm Holdings Inc.), a notable stock in the market. In this article, we will delve into the technical analysis of AFRM's recent movements and explore the implications of its earnings results.
Among them, the Swing Trader: Volatility Balanced Strategy (TA) stands out as a top-performing AI trading robot. In the previous week, this robot demonstrated its prowess by generating an impressive 3.60% gain while trading NET (stock ticker symbol) – a remarkable achievement. This article delves into the reasons behind the success of Swing Trader, focusing on the positive Moving Average Convergence Divergence (MACD) indicator and the recent earning results of NET.
The Swing Trader: Volatility Balanced Strategy (TA), has caught our attention for its impressive performance. Last week, it generated a remarkable gain of 3.56% while trading RIOT, a prominent stock. In this article, we will delve into the analysis of RIOT's recent bearish trend and examine the company's earnings results, which exceeded expectations.
The Swing Trader: Volatility Balanced Strategy (TA) AI trading robot has emerged as a top performer in our robot factory, demonstrating exceptional performance and generating significant gains. In the previous week, this intelligent trading bot achieved a remarkable 3.56% gain while trading WKHS (Workhorse Group Inc.) - an achievement worth noting. Coupled with positive market indicators, WKHS presents an intriguing opportunity for potential future growth.
AI trading robot, known as "Swing trader: Volatility Balanced Strategy (TA)," has caught the attention of traders and investors alike. In the previous week, this AI robot, developed in our esteemed robot factory, demonstrated impressive performance by generating a gain of 3.51% while trading DKNG. This article will delve into the recent trading activity, the significance of the stock's upward trend, and analyze the latest earnings results of DKNG.
One such tool that has garnered attention is the AI trading robot known as Swing trader: Volatility Balanced Strategy (TA). This robot, developed in our esteemed factory, recently demonstrated its prowess by generating a notable 3.02% gain while trading CHPT (ChargePoint Holdings) over the previous week. While CHPT experienced a downward trend, the robot's performance and insightful analysis provide valuable insights for traders and investors alike.
Explore the financial battleground between JNJ, a medium-volatility swing trading choice, and MRK, a popular stock for trend trading. Delving into their current performances, JNJ shows a gain of 3.04% while MRK rises by 6.71%. The analysis combines Technical Analysis (TA) & Fundamental Analysis (FA) for precise forecasting. Gain insights into market trends, financial stability, and future stock movement predictions for informed investment decisions.
Dive into a comparative analysis between the Market Neutral Strategy applied to CCL (yielding 15.39%) and the Swing Trading Strategy applied to MULN (yielding 19%). Both employ technical and fundamental analysis. Discover how the Motor Vehicles sector (+2.11% weekly) and Other Consumer Services (+3.75% weekly) affect these strategies. Earnings for CCL and MULN are expected on Sep 28 and May 31 respectively